Molecular modelling's $10-million comeback?
Friday, May 7, 2010 - 10:21
in Mathematics & Economics
Is Bill Gates's decision to invest in software company Schrödinger an early sign of a new computer-aided era for drug design, asks Derek Lowe. Or is it just another small step on what's been a rather lengthy journey?